Pavlo Gilchuk

9.3k total citations · 3 hit papers
49 papers, 2.4k citations indexed

About

Pavlo Gilchuk is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Pavlo Gilchuk has authored 49 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 22 papers in Immunology and 19 papers in Epidemiology. Recurrent topics in Pavlo Gilchuk's work include Viral Infections and Outbreaks Research (14 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Immune Cell Function and Interaction (12 papers). Pavlo Gilchuk is often cited by papers focused on Viral Infections and Outbreaks Research (14 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Immune Cell Function and Interaction (12 papers). Pavlo Gilchuk collaborates with scholars based in United States, Ukraine and Australia. Pavlo Gilchuk's co-authors include James E. Crowe, Sebastian Joyce, Robert H. Carnahan, Seth J. Zost, Rachel E. Sutton, Naveenchandra Suryadevara, Nurgun Kose, Rachel S. Nargi, Elad Binshtein and Kelli L. Boyd and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Pavlo Gilchuk

46 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

2020 568 citations Allison J. Greaney, Tyler N. Starr et al. Cell Host & Microbe profile →
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

2021 215 citations Naveenchandra Suryadevara, Swathi Shrihari et al. Cell profile →
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection

2021 183 citations Emma S. Winkler, Pavlo Gilchuk et al. Cell profile →

Peers

Countries citing papers authored by Pavlo Gilchuk

Since Specialization

Citations

This map shows the geographic impact of Pavlo Gilchuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavlo Gilchuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavlo Gilchuk more than expected).

Fields of papers citing papers by Pavlo Gilchuk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pavlo Gilchuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavlo Gilchuk. The network helps show where Pavlo Gilchuk may publish in the future.

Co-authorship network of co-authors of Pavlo Gilchuk

This figure shows the co-authorship network connecting the top 25 collaborators of Pavlo Gilchuk. A scholar is included among the top collaborators of Pavlo Gilchuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pavlo Gilchuk. Pavlo Gilchuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system 2024 ·Communications Biology ·Philipp A. Ilinykh, Kai Huang, Bronwyn M. Gunn, Natalia A. Kuzmina, (unknown), (unknown), Fuchun Zhou, Chandru Subramani, (unknown), (unknown), Lauren E. Williamson, Pavlo Gilchuk, Robert H. Carnahan, (unknown), James E. Crowe, Alexander Bukreyev	3
2	A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protection 2023 ·Cell Reports Medicine ·Lucas J. Adams, Laura A. VanBlargan, Zhuoming Liu, Pavlo Gilchuk, Haiyan Zhao, Rita E. Chen, Saravanan Raju, Zhenlu Chong, Bradley Whitener, Swathi Shrihari, (unknown), Michael L. Gross, James E. Crowe, Sean P. J. Whelan, Michael Diamond, Daved H. Fremont	5
3	Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region 2022 ·PLoS Pathogens ·Clara T. Schoeder, Pavlo Gilchuk, Amandeep K. Sangha, (unknown), Delphine C. Malherbe, Xuan Zhang, Elad Binshtein, Lauren E. Williamson, (unknown), Jinhui Dong, Erica Armstrong, Rachel E. Sutton, Rachel S. Nargi, Jessica Rodríguez, Natalia A. Kuzmina, Brooke Fiala, Neil P. King, Alexander Bukreyev, James E. Crowe, Jens Meiler	8
4	Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection breakdown → 2021 ·Cell ·Emma S. Winkler, Pavlo Gilchuk, Jinsheng Yu, Adam L. Bailey, Rita E. Chen, Zhenlu Chong, Seth J. Zost, Hyesun Jang, Ying Huang, James D. Allen, James Brett Case, Rachel E. Sutton, Robert H. Carnahan, Tamarand L. Darling, Adrianus C. M. Boon, Matthias Mack, Richard D. Head, Ted M. Ross, James E. Crowe, Michael Diamond	183
5	Pan-ebolavirus protective therapy by two multifunctional human antibodies 2021 ·Cell ·Pavlo Gilchuk, Charles D. Murin, Robert W. Cross, Philipp A. Ilinykh, Kai Huang, Natalia A. Kuzmina, Viktoriya Borisevich, Krystle N. Agans, Joan B. Geisbert, Seth J. Zost, Rachel S. Nargi, Rachel E. Sutton, Naveenchandra Suryadevara, Robin Bombardi, Robert H. Carnahan, Alexander Bukreyev, Thomas W. Geisbert, Andrew B. Ward, James E. Crowe	23
6	Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies 2021 ·Cell Reports ·Charles D. Murin, Pavlo Gilchuk, Philipp A. Ilinykh, Kai Huang, Natalia A. Kuzmina, Xiaoli Shen, Jessica F. Bruhn, Aubrey L. Bryan, Edgar Davidson, Benjamin J. Doranz, Lauren E. Williamson, Jeffrey Copps, (unknown), Andrew I. Flyak, Alexander Bukreyev, James E. Crowe, Andrew B. Ward	19
7	Discovery of Marburg virus neutralizing antibodies from virus-naïve human antibody repertoires using large-scale structural predictions 2020 ·Proceedings of the National Academy of Sciences ·Nina G. Bozhanova, Amandeep K. Sangha, Alexander M. Sevy, Pavlo Gilchuk, Kai Huang, Rachel S. Nargi, Joseph X. Reidy, Andrew Trivette, Robert H. Carnahan, Alexander Bukreyev, James E. Crowe, Jens Meiler	9
8	Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition breakdown → 2020 ·Cell Host & Microbe ·Allison J. Greaney, Tyler N. Starr, Pavlo Gilchuk, Seth J. Zost, Elad Binshtein, Andrea N. Loes, Sarah K. Hilton, John Huddleston, Rachel Eguia, Katharine H. D. Crawford, Adam S. Dingens, Rachel S. Nargi, Rachel E. Sutton, Naveenchandra Suryadevara, Paul W. Rothlauf, Zhuoming Liu, Sean P. J. Whelan, Robert H. Carnahan, James E. Crowe, Jesse D. Bloom	568
9	Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice 2019 ·Cell Host & Microbe ·Iuliia M. Gilchuk, Sandhya Bangaru, Pavlo Gilchuk, Ryan P. Irving, Nurgun Kose, Robin Bombardi, Natalie J. Thornburg, C. Buddy Creech, Kathryn M. Edwards, Sheng Li, Hannah L. Turner, Wenli Yu, Xueyong Zhu, Ian A. Wilson, Andrew B. Ward, James E. Crowe	44
10	High frequency of shared clonotypes in human B cell receptor repertoires 2019 ·Nature ·Cinque Soto, Robin Bombardi, Andre Branchizio, Nurgun Kose, Pranathi Matta, Alexander M. Sevy, Robert S. Sinkovits, Pavlo Gilchuk, Jessica A. Finn, James E. Crowe	162
11	A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface 2019 ·Cell ·Sandhya Bangaru, Shanshan Lang, Michael Schotsaert, Hillary A. Vanderven, Xueyong Zhu, Nurgun Kose, Robin Bombardi, Jessica A. Finn, Stephen J. Kent, Pavlo Gilchuk, Iuliia M. Gilchuk, Hannah L. Turner, Adolfo Garcı́a-Sastre, Sheng Li, Andrew B. Ward, Ian A. Wilson, James E. Crowe	153
12	Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors 2018 ·Cell Reports ·Natalia A. Kuzmina, Patrick Younan, Pavlo Gilchuk, Rodrigo I. Santos, Andrew I. Flyak, Philipp A. Ilinykh, Kai Huang, Ndongala Michel Lubaki, Palaniappan Ramanathan, James E. Crowe, Alexander Bukreyev	55
13	Identifying and Tracking Low-Frequency Virus-Specific TCR Clonotypes Using High-Throughput Sequencing 2018 ·Cell Reports ·Kyle J. Wolf, Tyler Hether, Pavlo Gilchuk, Amrendra Kumar, Ahmad Rajeh, (unknown), (unknown), R. Mark L. Buller, Tae-Hyuk Ahn, Sebastian Joyce, Richard J. DiPaolo	20
14	A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA 2018 ·Nature Communications ·Sandhya Bangaru, H. Zhang, Iuliia M. Gilchuk, Thomas G. Voss, Ryan P. Irving, Pavlo Gilchuk, Pranathi Matta, Xueyong Zhu, Shanshan Lang, Travis Nieusma, Jüergen A. Richt, Randy A. Albrecht, Hillary A. Vanderven, Robin Bombardi, Stephen J. Kent, Andrew B. Ward, Ian A. Wilson, James E. Crowe	75
15	Poly(propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines 2018 ·Biomaterials ·Feng Qiu, Kyle W. Becker, Frances C. Knight, Jessalyn J. Baljon, Sema Sevimli, Daniel Shae, Pavlo Gilchuk, Sebastian Joyce, John T. Wilson	76
16	A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein 2017 ·Nature Microbiology ·Jarrod J. Mousa, Nurgun Kose, Pranathi Matta, Pavlo Gilchuk, James E. Crowe	80
17	A Distinct Lung-Interstitium-Resident Memory CD8+ T Cell Subset Confers Enhanced Protection to Lower Respiratory Tract Infection 2016 ·Cell Reports ·Pavlo Gilchuk, Timothy Hill, Clifford S. Guy, Sean R. McMaster, Kelli L. Boyd, Whitney Rabacal, Lu Wang, Yu Shyr, Jacob E. Kohlmeier, Eric Sebzda, Douglas R. Green, Sebastian Joyce	59
18	Discovering protective CD8 T cell epitopes—no single immunologic property predicts it! 2015 ·Current Opinion in Immunology ·Pavlo Gilchuk, Timothy Hill, John T. Wilson, Sebastian Joyce	17
19	Border Patrol Gone Awry: Lung NKT Cell Activation by Francisella tularensis Exacerbates Tularemia-Like Disease 2015 ·PLoS Pathogens ·Timothy Hill, Pavlo Gilchuk, (unknown), (unknown), Kelli L. Boyd, Douglas M. Durrant, Dennis W. Metzger, Kamal M. Khanna, Sebastian Joyce	16
20	Myeloid IKKβ Promotes Antitumor Immunity by Modulating CCL11 and the Innate Immune Response 2014 ·Cancer Research ·Jinming Yang, Oriana E. Hawkins, Whitney Barham, Pavlo Gilchuk, Mark Boothby, Gregory D. Ayers, Sebastian Joyce, Michael Karin, Fiona E. Yull, Ann Richmond	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact